184 related articles for article (PubMed ID: 12112397)
1. 5-HT6 receptor binding sites in schizophrenia and following antipsychotic drug administration: autoradiographic studies with [125I]SB-258585.
East SZ; Burnet PW; Leslie RA; Roberts JC; Harrison PJ
Synapse; 2002 Sep; 45(3):191-9. PubMed ID: 12112397
[TBL] [Abstract][Full Text] [Related]
2. 5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus.
Li Z; Huang M; Prus AJ; Dai J; Meltzer HY
Brain Res; 2007 Feb; 1134(1):70-8. PubMed ID: 17207474
[TBL] [Abstract][Full Text] [Related]
3. Expression of serotonin 5-HT(2A) receptors in the human cerebellum and alterations in schizophrenia.
Eastwood SL; Burnet PW; Gittins R; Baker K; Harrison PJ
Synapse; 2001 Nov; 42(2):104-14. PubMed ID: 11574947
[TBL] [Abstract][Full Text] [Related]
4. Treatment with haloperidol and diazepam alters GABA(A) receptor density in the rat brain.
McLeod MC; Sundram S; Dean B
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):560-7. PubMed ID: 18045761
[TBL] [Abstract][Full Text] [Related]
5. 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia.
Burnet PW; Eastwood SL; Harrison PJ
Neuropsychopharmacology; 1996 Nov; 15(5):442-55. PubMed ID: 8914117
[TBL] [Abstract][Full Text] [Related]
6. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
Bruins Slot LA; Lestienne F; Grevoz-Barret C; Newman-Tancredi A; Cussac D
Eur J Pharmacol; 2009 Oct; 620(1-3):27-35. PubMed ID: 19695244
[TBL] [Abstract][Full Text] [Related]
7. The atypical antipsychotic drug clozapine enhances chronic PCP-induced regulation of prefrontal cortex 5-HT2A receptors.
Steward LJ; Kennedy MD; Morris BJ; Pratt JA
Neuropharmacology; 2004 Sep; 47(4):527-37. PubMed ID: 15380371
[TBL] [Abstract][Full Text] [Related]
8. Selective increases in the cytokine, TNFalpha, in the prefrontal cortex of PCP-treated rats and human schizophrenic subjects: influence of antipsychotic drugs.
Paterson GJ; Ohashi Y; Reynolds GP; Pratt JA; Morris BJ
J Psychopharmacol; 2006 Sep; 20(5):636-42. PubMed ID: 16478754
[TBL] [Abstract][Full Text] [Related]
9. Distribution of beta-adrenergic receptor subtypes in human post-mortem brain: alterations in limbic regions of schizophrenics.
Joyce JN; Lexow N; Kim SJ; Artymyshyn R; Senzon S; Lawrence D; Cassanova MF; Kleinman JE; Bird ED; Winokur A
Synapse; 1992 Mar; 10(3):228-46. PubMed ID: 1313605
[TBL] [Abstract][Full Text] [Related]
10. Alterations in the cortical serotonergic system in schizophrenia: a postmortem study.
Gurevich EV; Joyce JN
Biol Psychiatry; 1997 Oct; 42(7):529-45. PubMed ID: 9376449
[TBL] [Abstract][Full Text] [Related]
11. Mapping of serotonin 5-HT(4) receptor mRNA and ligand binding sites in the post-mortem human brain.
Bonaventure P; Hall H; Gommeren W; Cras P; Langlois X; Jurzak M; Leysen JE
Synapse; 2000 Apr; 36(1):35-46. PubMed ID: 10700024
[TBL] [Abstract][Full Text] [Related]
12. Antipsychotic drugs reverse the AMPA receptor-stimulated release of 5-HT in the medial prefrontal cortex.
Amargós-Bosch M; Adell A; Artigas F
J Neurochem; 2007 Jul; 102(2):550-61. PubMed ID: 17394545
[TBL] [Abstract][Full Text] [Related]
13. Lack of localization of 5-HT6 receptors on cholinergic neurons: implication of multiple neurotransmitter systems in 5-HT6 receptor-mediated acetylcholine release.
Marcos B; Gil-Bea FJ; Hirst WD; García-Alloza M; Ramírez MJ
Eur J Neurosci; 2006 Sep; 24(5):1299-306. PubMed ID: 16987217
[TBL] [Abstract][Full Text] [Related]
14. Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis.
Kuroki T; Nagao N; Nakahara T
Prog Brain Res; 2008; 172():199-212. PubMed ID: 18772034
[TBL] [Abstract][Full Text] [Related]
15. Expression of complexin I and II mRNAs and their regulation by antipsychotic drugs in the rat forebrain.
Eastwood SL; Burnet PW; Harrison PJ
Synapse; 2000 Jun; 36(3):167-77. PubMed ID: 10819897
[TBL] [Abstract][Full Text] [Related]
16. Effects of divalproex and atypical antipsychotic drugs on dopamine and acetylcholine efflux in rat hippocampus and prefrontal cortex.
Huang M; Li Z; Ichikawa J; Dai J; Meltzer HY
Brain Res; 2006 Jul; 1099(1):44-55. PubMed ID: 16824491
[TBL] [Abstract][Full Text] [Related]
17. Serotonin receptors: their key role in drugs to treat schizophrenia.
Meltzer HY; Li Z; Kaneda Y; Ichikawa J
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1159-72. PubMed ID: 14642974
[TBL] [Abstract][Full Text] [Related]
18. Differences in the cellular distribution of D1 receptor mRNA in the hippocampus of bipolars and schizophrenics.
Pantazopoulos H; Stone D; Walsh J; Benes FM
Synapse; 2004 Dec; 54(3):147-55. PubMed ID: 15452863
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of rat 5-HT2A and 5-HT2C receptors after chronic treatment with clozapine, chlorpromazine and three putative atypical antipsychotic drugs.
Kuoppamäki M; Pälvimäki EP; Hietala J; Syvälahti E
Neuropsychopharmacology; 1995 Oct; 13(2):139-50. PubMed ID: 8597525
[TBL] [Abstract][Full Text] [Related]
20. Dynamic regulation of glutamatergic postsynaptic activity in rat prefrontal cortex by repeated administration of antipsychotic drugs.
Fumagalli F; Frasca A; Racagni G; Riva MA
Mol Pharmacol; 2008 May; 73(5):1484-90. PubMed ID: 18250147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
